Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has informed BSE that a meeting of its Board of Directors is scheduled for November 7, 2025. The primary agenda is to consider and approve the Unaudited Financial Results for the half year ended September 30, 2025. The company has also confirmed that the trading window for designated persons is already closed since October 1, 2025, and will reopen 48 hours after the results are announced. The intimation is filed under SEBI Listing Regulations, 2015.
This is a routine regulatory filing. No new financial data is disclosed at this stage; investors should await the actual half-yearly results on November 7 for insights into the company's performance. The closed trading window restricts insider transactions until results are published.